Is the endotoxin-complement cascade the major driver in lipedema?

Kruglikov IL, Scherer PE
Trends in endocrinology and metabolism: TEM · 29 abr 2024 · DOI 10.1038/s41574-023-00900-w · PMID 38688780

Abstract original

Lipedema is a poorly understood disorder of adipose tissue characterized by abnormal but symmetrical deposition of subcutaneous white adipose tissue (WAT) in proximal extremities. Here, we propose that the underlying cause for lipedema could be triggered by a selective accumulation of bacterial lipopolysaccharides (LPS; also known as endotoxin) in gluteofemoral WAT. Together with a malfunctioning complement system, this induces low-grade inflammation in the depot and raises its uncontrollable expansion. Correspondingly, more attention should be paid in future research to the endotoxemia prevalent in patients with lipedema. We would like to propose that proper management of endotoxemia can reduce the progression and even improve the state of disease in patients with lipedema.

Mais em Genética e fisiopatologia

Nível de evidência 3 de 5

Lipedema research (2000-2025): a global bibliometric analysis with evidence of an emerging immunological paradigm

The aim of this study was to characterize global scientific output on lipedema from 2000 to 2025 and identify emerging thematic trends, with emphasis on the emergence of immunological research. Publications indexed in Google…

Amato ACM, Amato JLS, Benitti DA · Revista da Associacao Medica Brasileira (1992) · 16 out 2026

Nível de evidência 2 de 5

Narrative Review of Pathogenetic Mechanisms and Diagnostic Biomarkers in Adipose Tissue Remodelling and Adipokine Dysregulation in Lipedema

Aim: This narrative review summarises evidence on pathogenetic mechanisms of adipose tissue remodelling and adipokine dysregulation in lipedema, focusing on adipocyte hypertrophy and hyperplasia, fibrosis, microcirculatory and…

Sierawska O, Dudzińska W · Current issues in molecular biology · 7 out 2026